financetom
Business
financetom
/
Business
/
RBC Capital Markets Details Takeaways From Crescent Point's Investor Day
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RBC Capital Markets Details Takeaways From Crescent Point's Investor Day
Mar 25, 2024 7:31 AM

10:07 AM EDT, 03/25/2024 (MT Newswires) -- RBC Capital Markets on Monday outlined highlights from Crescent Point Energy Corp. ( CPG ) 's Investor Day in Calgary.

RBC said the company focused on technical details regarding its Montney/Duvernay plays as well as its medium/long term outlook.

RBC reiterated its constructive stance on the company, saying that its outlook for Crescent Point is "predicated on drama-free execution" in 2024 as it pays down debt and looks to increase its payout.

RBC noted that the company will change its name to Veren Inc. following shareholder approval.

Price: 10.79, Change: +0.20, Percent Change: +1.89

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
American Battery Technology (ABAT) Stock Is Rising: What's Going On?
American Battery Technology (ABAT) Stock Is Rising: What's Going On?
Oct 13, 2025
Shares of American Battery Technology Co ( ABAT ) are trading higher Monday morning after the company announced it has completed a critical step in developing its Tonopah Flats Lithium Project in Nevada. Here’s what investors need to know. What To Know: American Battery ( ABAT ) has finished all required National Environmental Policy Act (NEPA) baseline studies and submitted...
AbbVie Gains FDA Approval for Expanded Rinvoq Use in IBD Patients
AbbVie Gains FDA Approval for Expanded Rinvoq Use in IBD Patients
Oct 13, 2025
11:24 AM EDT, 10/13/2025 (MT Newswires) -- AbbVie ( ABBV ) said Monday that the US Food and Drug Administration approved an updated Rinvoq indication for adults with moderately to severely active ulcerative colitis and Crohn's disease. The updated label permits Rinvoq use before tumor necrosis factor blockers for patients unsuited to TNF inhibitors who have tried at least one...
Oklo Stock Surges To New All-Time Highs Monday: What's Driving The Action?
Oklo Stock Surges To New All-Time Highs Monday: What's Driving The Action?
Oct 13, 2025
Shares of Oklo Inc ( OKLO ) soared to a new all-time high Monday morning, continuing a powerful rally fueled by optimistic analyst coverage and increasing demand for clean energy. Here’s what investors need to know. What To Know: The advanced nuclear energy company has gained 1,600% over the past year, driven by the growing need for reliable power for...
Airbus sees supply progress, Spirit deal to close in fourth quarter
Airbus sees supply progress, Spirit deal to close in fourth quarter
Oct 13, 2025
PARIS (Reuters) -Airbus has seen a marked improvement in confidence and performance from its suppliers, all of whom are ready to support the company's target of increasing deliveries by 7% to some 820 jets this year, a senior company official said on Monday. The European planemaker is also on its way towards a longer-term goal of increasing underlying output of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved